Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. depressing
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Depressing Articles & Analysis: Older

162 news found

Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry

Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry

Regular intake has been demonstrated to reduce symptoms of depression and anxiety, enhance fetal brain development, and lower heart disease risks by managing cholesterol and blood pressure levels. ...

ByAlfa Chemistry


Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

Psychiatric drug development is a crucial aspect of mental health treatment, as it involves the development of medications that can effectively treat various psychiatric disorders such as depression, anxiety, schizophrenia, and others. The process of antipsychiatric drug development typically involves several stages, including identifying potential drug targets, conducting ...

ByAce Therapeutics


CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials

CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials

CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare ...

ByCanaQuest Medical Corp.


Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

It is US FDA-cleared to be used in line with any shunt system brand to flush the patient’s CSF back into the ventricular catheter to improve, restore, and maintain hydrocephalus shunt flow, with a simple finger depression of the flusher’s soft dome implanted beneath the patient’s scalp. ...

ByAnuncia Medical, Inc.


AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

Our Risk-based analytics engine can find members with, for example, high-predicted probability of substance use disorder or depression, but no associated diagnosis in existing health records. This technology helps drive Ontrak's impressive member outreach success of 54% across all lines of business, which Ontrak believes is more than double the industry standard. ...

ByInvestorideas.com


NGE`s support for TU Braunschweig`s iGEM 2023 victory

NGE`s support for TU Braunschweig`s iGEM 2023 victory

The iGEM (International Genetically Engineered Machine) Competition is an annual event in synthetic biology. Teams participating in iGEM typically spend several months conducting research, designing their projects, and building their biological systems. These projects can range from addressing real-world problems in areas such as healthcare, environmental sustainability, and manufacturing, to ...

ByNippon Genetics Europe


Dreams and Sleep Quality:  Finding the Best Anti-Snoring Device

Dreams and Sleep Quality: Finding the Best Anti-Snoring Device

These concerns include compromised memory as well as the correlation between anxiety and ...

ByTannerMedico A/S - Asonor


ASMR for Sleep - Benefits and Snoring Solutions

ASMR for Sleep - Benefits and Snoring Solutions

Have you heard of the sensory phenomenon known as ASMR for sleep? ASMR stands for autonomous sensory meridian response, a condition, experience, or phenomenon that helps you fall asleep. As a form of parasthesia (a group or series of sensations felt in the skin), ASMR is perceived as a pleasant experience that is characterized by a tingling sensation in the neck and scalp areas that are ...

ByTannerMedico A/S - Asonor


MedSource Corporate Wellness Tips: Create A Culture of Gratitude With Your Team

MedSource Corporate Wellness Tips: Create A Culture of Gratitude With Your Team

Thanksgiving is a time when families gather around the table to give thanks for their blessings, share a delicious meal, and create memories. It’s a holiday that encourages us to reflect on what we are grateful for and appreciate the people and opportunities in our lives. While Thanksgiving is traditionally a family-centric holiday, it’s also an excellent opportunity for businesses to ...

ByMedsource Labs


NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...

ByCanaQuest Medical Corp.


Anuncia Releases User Guide Video for the ReFlow Mini Flusher

Anuncia Releases User Guide Video for the ReFlow Mini Flusher

The flusher dome has a noticeable resistance to compression and cannot be depressed. The flusher dome does not refill. To see video, please click ...

ByAnuncia Medical, Inc.


Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of life. Depression is commonly seen in neurodegenerative and neurodevelopmental diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and autism spectrum disorders. Although the exact ...

ByProtheragen


CANAQUEST Announces Award of European Cannabinoid Patent

CANAQUEST Announces Award of European Cannabinoid Patent

Pre-clinical trials have demonstrated the reversal of depression-like and schizophrenia-related symptoms, blockage of memory impairment, hyperactive activity, and gene vulnerability. ...

ByCanaQuest Medical Corp.


Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Used in line with any shunt system brand, the ReFlow Mini Flusher is designed to flush the patient’s CSF back into the ventricular catheter to maintain, restore or increase hydrocephalus shunt flow, with just a simple finger depression of the flusher’s soft dome located beneath the patient’s scalp. ...

ByAnuncia Medical, Inc.


CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and Pharmaceutical ...

ByCanaQuest Medical Corp.


CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine

CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine

The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder "PTSD", including addiction. ...

ByCanaQuest Medical Corp.


Nanoparticulate Peptide Delivery Exclusively To The Brain Produces Tolerance Free Analgesia

Nanoparticulate Peptide Delivery Exclusively To The Brain Produces Tolerance Free Analgesia

We believe the preliminary data from these early animal studies of NES100 support our belief that Envelta™ may have comparable preclinical activity to morphine in all animal pain models tested without the drug seeking, respiratory depression, and tolerance associated with opioids. Currently, enkephalins are limited in their therapeutic potential by their pharmacokinetic ...

ByVirpax Pharmaceuticals


Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Eagle Pharmaceuticals Provides Business Update and Guidance for 2023

Commercial and Pipeline Update Product portfolio Acute Care Hospital: RYANODEX®, vasopressin, Barhemsys®, Byfavo® Oncology: BENDEKA, BELRAPZO, PEMFEXY11, TREAKISYM Japan12 75-person commercial team covers all products excluding BENDEKA and TREAKISYM Company projects growth in earnings while still supporting R&D Cash flow from legacy products expected to continue to ...

ByEagle Pharmaceuticals, Inc.


Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

The PTR platform has the opportunity to be used for delivery of medications in other large markets, including anxiety (CTx-2103 in development), insomnia, depression, bipolar disorder, Parkinson’s disease, xerostomia (dry mouth), migraine, and hypothyroidism. ...

ByCingulate


Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone

Tris Pharma Reports Positive Topline Data from Clinical Study of Investigational Pain Therapy Cebranopadol Showing Significantly Less Potential for Abuse Versus Tramadol and Oxycodone

“Cebranopadol is so exciting because preliminary data suggest that it can treat pain as effectively as opioids but has much lower potential for abuse, produces significantly less respiratory depression and leads to negligible physical dependence. The results of this trial seem to definitively prove that the drug has a low potential for abuse, and if the other features of ...

ByTris Pharma, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT